All In MedTech

FDA Clearance Tracker · P100044-S018

PROPEL MINI SINUS IMPLANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 23, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 23, 2016

Approved

Time to decision

180 days

Received Sep 25, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P100044-S018
Device name
PROPEL MINI SINUS IMPLANT
Applicant location
Menlo Park, CA
Received
Sep 25, 2015
Decided
Mar 23, 2016
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P100044

Device type

Device class
Class III

Every decision under product code OWO

FDA's approval statement

As written in FDA's record.

Approval for the PROPEL Mini Sinus Implant is intended for use in patients >= 18 years of age following ethmoid/frontal sinus surgery to maintain patency of the ethmoid sinus or frontal sinus opening. The PROPEL Mini Sinus Implant separates/dilates surrounding mucosal tissues, provides stabilization of the middle turbinate, prevents obstruction by adhesions, and reduces inflammation. The implant reduces the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids.

Source documents

Other decisions for Intersect Ent.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.